Abstract
Recent studies have shown that there is an interaction between fat and bone metabolisms. Adipose tissue secretes leptin and adiponectin to regulate bone metabolism. Leptin inhibits bone formation by activating the sympathetic nervous system, whereas the peripheral pathway of leptin shows a positive effect on bone formation. Opposite to leptin, adiponectin enhances or inhibits bone formation osteoblast in the central or peripheral respectively. On the other hand, osteocalcin (OCN) is decarboxylated and released from skeleton as the hormonal form of undercarboxylated-osteocalcin (ucOCN) to stimulate islets and fat to secret insulin and adiponectin respectively, thus to regulate energy metabolism. All these data indicate that there exist complex regulatory loops within fat and bone endocrine networks. In this review, we will elucidate the hormones and their receptors that mediate the communication between fat and bone metabolisms.
Keywords: Adiponectin, bone metabolism, fat metabolism, leptin, osteocalcin.
Current Signal Transduction Therapy
Title:Hormones and their Receptors Bridge Fat and Bone Metabolisms
Volume: 10 Issue: 1
Author(s): Chunyu Wang, Li Tian and Xijie Yu
Affiliation:
Keywords: Adiponectin, bone metabolism, fat metabolism, leptin, osteocalcin.
Abstract: Recent studies have shown that there is an interaction between fat and bone metabolisms. Adipose tissue secretes leptin and adiponectin to regulate bone metabolism. Leptin inhibits bone formation by activating the sympathetic nervous system, whereas the peripheral pathway of leptin shows a positive effect on bone formation. Opposite to leptin, adiponectin enhances or inhibits bone formation osteoblast in the central or peripheral respectively. On the other hand, osteocalcin (OCN) is decarboxylated and released from skeleton as the hormonal form of undercarboxylated-osteocalcin (ucOCN) to stimulate islets and fat to secret insulin and adiponectin respectively, thus to regulate energy metabolism. All these data indicate that there exist complex regulatory loops within fat and bone endocrine networks. In this review, we will elucidate the hormones and their receptors that mediate the communication between fat and bone metabolisms.
Export Options
About this article
Cite this article as:
Wang Chunyu, Tian Li and Yu Xijie, Hormones and their Receptors Bridge Fat and Bone Metabolisms, Current Signal Transduction Therapy 2015; 10 (1) . https://dx.doi.org/10.2174/157436241001150728124635
DOI https://dx.doi.org/10.2174/157436241001150728124635 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Cell Cycle and Cancer: The G1 Restriction Point and the G1 / S Transition
Current Genomics Quantification of Specific Glycation Sites in Human Serum Albumin as Prospective Type 2 Diabetes Mellitus Biomarkers
Protein & Peptide Letters Editorial (Thematic Issue: Endothelium: A Target for Therapeutic Intervention)
Current Vascular Pharmacology Phytochemical Composition, Biological Activities and Processing Method of Genus <i>Anisophyllea</i>: A Review
The Natural Products Journal Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety Complications of the Type 2 Diabetes Mellitus
Current Cardiology Reviews Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all
Current Pharmaceutical Design Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design PDX-1 and MafA as Potential Therapeutic Targets for Diabetes
Current Signal Transduction Therapy Metabolic Enzymes of Helminth Parasites: Potential as Drug Targets
Current Protein & Peptide Science Patent Selections
Recent Patents on Biomarkers Role of Insulin in Glucose-Stimulated Insulin Secretion in Beta Cells
Current Diabetes Reviews Use of Metformin and Survival of Diabetic Women with Breast Cancer
Current Drug Safety Recent Developments in Patents Targeting Toll-Like Receptor Genes
Recent Patents on DNA & Gene Sequences Premature Ageing Prevention: Limitations and Perspectives of Pharmacological Interventions
Current Drug Targets Physical Activity and Insulin Resistance
Current Nutrition & Food Science Association of Thrombospondin-1 (N700S) and Thrombospond in-4 (A387P) Gene Polymorphisms with the Incidence of Acute Myocardial Infarction in Egyptians
Current Pharmaceutical Biotechnology Effects of Imidazolic Agonism on Blood Pressure, Sympathetic Activity, Left Ventricular Hypertrophy and Insulin Resistance
Current Hypertension Reviews Vasopeptidase Inhibition for Blood Pressure Control: Emerging Experience
Current Pharmaceutical Design